Biophytis Stock Current Valuation
Valuation analysis of Biophytis helps investors to measure Biophytis' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Biophytis Company Current Valuation Analysis
Biophytis' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Biophytis Current Valuation | 9.73 B |
Most of Biophytis' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biophytis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Biophytis has a Current Valuation of 9.73 B. This is 32.26% lower than that of the Biotechnology sector and 109.45% higher than that of the Health Care industry. The current valuation for all United States stocks is 41.47% higher than that of the company.
Biophytis Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biophytis' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics of similar companies.Biophytis is currently under evaluation in current valuation category among its peers.
Biophytis Fundamentals
Return On Equity | -12.44 | |||
Return On Asset | -0.53 | |||
Current Valuation | 9.73 B | |||
Shares Outstanding | 286.5 K | |||
Shares Owned By Institutions | 0.04 % | |||
Number Of Shares Shorted | 368.95 K | |||
Price To Book | 2.26 X | |||
EBITDA | (15.09 M) | |||
Net Income | (17.03 M) | |||
Cash And Equivalents | 23.93 M | |||
Cash Per Share | 1.71 X | |||
Total Debt | 8.27 M | |||
Debt To Equity | 3.27 % | |||
Current Ratio | 1.37 X | |||
Book Value Per Share | (0) X | |||
Cash Flow From Operations | (13.33 M) | |||
Short Ratio | 0.41 X | |||
Earnings Per Share | (128.39) X | |||
Target Price | 6000.0 | |||
Number Of Employees | 22 | |||
Beta | 1.05 | |||
Market Capitalization | 2.61 M | |||
Total Asset | 11.94 M | |||
Retained Earnings | (19.38 M) | |||
Working Capital | (3.52 M) | |||
Net Asset | 11.94 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |